160 related articles for article (PubMed ID: 11920501)
1. Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma.
Meyer-Siegler KL; Bellino MA; Tannenbaum M
Cancer; 2002 Mar; 94(5):1449-56. PubMed ID: 11920501
[TBL] [Abstract][Full Text] [Related]
2. Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer.
Meyer-Siegler KL; Iczkowski KA; Vera PL
BMC Cancer; 2005 Jul; 5():73. PubMed ID: 16000172
[TBL] [Abstract][Full Text] [Related]
3. Increased stability of macrophage migration inhibitory factor (MIF) in DU-145 prostate cancer cells.
Meyer-Siegler K
J Interferon Cytokine Res; 2000 Sep; 20(9):769-78. PubMed ID: 11032396
[TBL] [Abstract][Full Text] [Related]
4. Expression of macrophage migration inhibitory factor in the human prostate.
Meyer-Siegler K; Fattor RA; Hudson PB
Diagn Mol Pathol; 1998 Feb; 7(1):44-50. PubMed ID: 9646034
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression.
Muramaki M; Miyake H; Yamada Y; Hara I
Oncol Rep; 2006 Jan; 15(1):253-7. PubMed ID: 16328065
[TBL] [Abstract][Full Text] [Related]
6. Gastric epithelial expression of macrophage migration inhibitory factor is not altered by Helicobacter pylori infection in humans.
Lebiedz P; Heidemann J; Lugering A; Riedel S; Herbst H; Domschke W; Kucharzik T; Maaser C
Helicobacter; 2006 Aug; 11(4):258-65. PubMed ID: 16882329
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic validity of macrophage migration inhibitory factor in serum of patients with prostate cancer: a re-evaluation.
Michael A; Stephan C; Kristiansen G; Burckhardt M; Loening SA; Schnorr D; Jung K
Prostate; 2005 Jan; 62(1):34-9. PubMed ID: 15389818
[TBL] [Abstract][Full Text] [Related]
8. Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis.
He XX; Yang J; Ding YW; Liu W; Shen QY; Xia HH
Gut; 2006 Jun; 55(6):797-802. PubMed ID: 16488898
[TBL] [Abstract][Full Text] [Related]
9. HIF-1alpha mRNA gene expression levels in improved diagnosis of early stages of prostate cancer.
Pipinikas CP; Carter ND; Corbishley CM; Fenske CD
Biomarkers; 2008 Nov; 13(7):680-91. PubMed ID: 19096962
[TBL] [Abstract][Full Text] [Related]
10. Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Tawadros T; Alonso F; Jichlinski P; Clarke N; Calandra T; Haefliger JA; Roger T
Endocr Relat Cancer; 2013 Feb; 20(1):137-49. PubMed ID: 23207293
[TBL] [Abstract][Full Text] [Related]
11. Higher expression of the androgen-regulated gene PSA/HK3 mRNA in prostate cancer tissues predicts biochemical recurrence-free survival.
Sterbis JR; Gao C; Furusato B; Chen Y; Shaheduzzaman S; Ravindranath L; Osborn DJ; Rosner IL; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S; Cullen J; Petrovics G
Clin Cancer Res; 2008 Feb; 14(3):758-63. PubMed ID: 18245536
[TBL] [Abstract][Full Text] [Related]
12. Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs.
Xia HH; Zhang ST; Lam SK; Lin MC; Kung HF; Wong BC
Carcinogenesis; 2005 Jan; 26(1):11-5. PubMed ID: 15358635
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
[TBL] [Abstract][Full Text] [Related]
14. Production and release of macrophage migration inhibitory factor from human adipocytes.
Skurk T; Herder C; Kräft I; Müller-Scholze S; Hauner H; Kolb H
Endocrinology; 2005 Mar; 146(3):1006-11. PubMed ID: 15576462
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor in the human prostate: identification and immunocytochemical localization.
Arcuri F; del Vecchio MT; de Santi MM; Lalinga AV; Pallini V; Bini L; Bartolommei S; Parigi S; Cintorino M
Prostate; 1999 May; 39(3):159-65. PubMed ID: 10334104
[TBL] [Abstract][Full Text] [Related]
16. Role of macrophage migration inhibitory factor in conjunctival pathology in ocular cicatricial pemphigoid.
Razzaque MS; Foster CS; Ahmed AR
Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1174-81. PubMed ID: 15037585
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.
Leech M; Metz C; Hall P; Hutchinson P; Gianis K; Smith M; Weedon H; Holdsworth SR; Bucala R; Morand EF
Arthritis Rheum; 1999 Aug; 42(8):1601-8. PubMed ID: 10446857
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes.
Takahashi M; Nishihira J; Shimpo M; Mizue Y; Ueno S; Mano H; Kobayashi E; Ikeda U; Shimada K
Cardiovasc Res; 2001 Dec; 52(3):438-45. PubMed ID: 11738060
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases.
Meyer-Siegler K; Hudson PB
Urology; 1996 Sep; 48(3):448-52. PubMed ID: 8804500
[TBL] [Abstract][Full Text] [Related]
20. Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread.
Bando H; Matsumoto G; Bando M; Muta M; Ogawa T; Funata N; Nishihira J; Koike M; Toi M
Jpn J Cancer Res; 2002 Apr; 93(4):389-96. PubMed ID: 11985788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
